Research progress of biomarkers for non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths worldwide.Despite growing efforts for its early detection by screening populations at risk,the majority of lung cancer patients are still diagnosed in an advanced stage.In the last decade,the treatment of non-small cell lung cancer(NSCLC)has been improved significantly.Emerging options of targeted therapies and immunotherapies have shifted the management of lung cancer to a more personalized treatment approach,significantly influencing the clinical course and outcome of the disease.At present,molecular biomarkers are becoming a powerful tool for diagnosing cancer,predicting treatment response outcomes,and assessing prognosis.In this review,we summarized the biomarkers relevant to the diagnosis,prediction,and prognosis of NSCLC as well as promising novel predictive biomarkers in the future.
万方数据
维普
